Basel, 30 June 2017 Roche acquires mySugr to form a leading open platform for digital diabetes management mySugr will become an integral part of Roche’s new patient-centred digital health services in diabetes care Healthcare providers can continue to utilise existing Accu-Chek tools to make better and faster therapy decisions while improving communication with their patients... Read more
June 29, 2017 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, acquired Trinean today. Trinean’s DropSense systems measure protein, DNA and RNA concentration in biologics and genomics samples. This is Unchained Labs’ 5th acquisition in just over 2 years. DropSense96 is the... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the 100,000 Genomes Project. In a little over a year since Illumina announced the Bioinformatics and Clinical Interpretation Partnership with Genomics England, the partnership has now set... Read more
Saluggia, Italy and Männedorf, Switzerland, June 23, 2017 – DiaSorin (FTSE Italy Mid Cap: DIA) and Tecan Group (SIX Swiss Exchange: TECN) announced today that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its Nucleic Acid extraction platform. The new platform will... Read more
June 22, 2017 – Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – DiaSorin (FTSE Italy Mid Cap: DIA) and QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) announced today a new collaboration to develop new tests for DiaSorin’s LIAISON family of analyzers based on a review and selection process involving QIAGEN’s assay technologies. The adoption of... Read more
BERWYN, Pa. and MINNEAPOLIS, June 22, 2017 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed its acquisition of MOCON, Inc. (NASDAQ: MOCO) for $30 per share in cash per fully diluted common share, or approximately $182 million net of cash acquired. The completion of the transaction follows approval from MOCON shareholders and... Read more
OAKLAND, Calif., June 22, 2017 /PRNewswire/ — CW Analytical Laboratories Inc., a leading laboratory in California’sCannabis industry, and Orange Photonics Inc, producer of portable Cannabinoid analyzers, are pleased to announce their distribution partnership throughout the state of California. Utilizing a modified version of the same high pressure liquid chromatography currently used to measure cannabinoid content in a laboratory setting, LightLab™... Read more
Canopy Biosciences signs agreement with Cosmo Bio to sell gene engineering products in Japan ST. LOUIS, June 22, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio“) for its TUNR Flexible Gene Editing technology in Japan. ... Read more
MOU signed between Mexico SAGARPA’s INIFAP and Seegene for collaborative product development and clinical study: (from middle to left) INIFAP’s bovine TB Director Dr. Ferando Otero, Head of Seegene Institute of Life Sciences Dr. Nackmoon … SEOUL, South Korea, June 21, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered... Read more
Accelerates revenue and earnings growth by adding leading positions in autoimmune and allergy diagnostics and strengthens leadership in China and other emerging markets Significant opportunity to leverage technologies, strong market positions and synergistic commercial activities to deliver better solutions across an expanding customer base Highly compelling deployment of capital, significantly advancing PerkinElmer’s strategic priorities and... Read more